Liquan Gao

Title: Innovations of Liquan Gao in Therapeutic Molecules

Introduction

Liquan Gao is a prominent inventor based in London, GB, known for his significant contributions to the field of therapeutic molecules. With a total of five patents to his name, Gao has made strides in the development of T cell receptor molecules that hold promise for treating malignancies.

Latest Patents

Gao's latest patents focus on therapeutically useful T cell receptor (TCR) molecules. These TCRs contain both an alpha chain portion and a beta chain portion, with the alpha chain featuring three complementarity determining regions (CDRs). The specific sequences of these CDRs are crucial for their functionality. The invention also encompasses polynucleotides encoding these TCR molecules and host cells that contain them. Patient-derived T cells can be engineered with these polynucleotides to combat WT1-expressing malignancies, showcasing the potential of his work in cancer therapy.

Career Highlights

Throughout his career, Liquan Gao has worked with notable companies such as Imperial Innovations Limited and Ganymed Pharmaceuticals AG. His experience in these organizations has contributed to his expertise in the field of therapeutic innovations.

Collaborations

Gao has collaborated with esteemed colleagues, including Hans Josef Stauss and Shao-An Xue, further enhancing the impact of his research and inventions.

Conclusion

Liquan Gao's innovative work in the development of T cell receptor molecules represents a significant advancement in therapeutic applications. His contributions continue to pave the way for new treatments in oncology.